BamSEC and AlphaSense Join Forces
Learn More

Metabasis Therapeutics Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 8-K 25 pages Contingent Value Rights Agreement
12/34/56
EX-10.3
from 8-K 21 pages Contingent Value Rights Agreement
12/34/56
EX-10.2
from 8-K 21 pages Contingent Value Rights Agreement
12/34/56
EX-10.1
from 8-K 20 pages Contingent Value Rights Agreement
12/34/56
EX-10.1
from 8-K 4 pages First Amendment to Agreement for Termination of Lease and Voluntary Surrender of Premises
12/34/56
EX-10.1
from 425 4 pages First Amendment to Agreement for Termination of Lease and Voluntary Surrender of Premises
12/34/56
EX-10.1
from 10-Q 2 pages Metabasis Therapeutics, Inc. Amendment to Offer Letter and Severance Agreement
12/34/56
EX-10.6
from 10-Q 45 pages Sellers/Listing Services Addendum Effective Date: July 14, 2009
12/34/56
EX-10.5
from 10-Q 21 pages Agreement for Termination of Lease and Voluntary Surrender of Premises
12/34/56
EX-10.4
from 10-Q 4 pages Amendment Between Merck & Co., Inc. and Metabasis Therapeutics, Inc
12/34/56
EX-10.3
from 10-Q 4 pages Metabasis Therapeutics, Inc. 11119 North Torrey Pines Road La Jolla, Ca 92037 USA Attention: Chief Executive Officer June 1, 2009 Re: Fourth Letter Agreement to Collaboration and License Agreement Ladies and Gentlemen
12/34/56
EX-10.1
from 10-Q 11 pages Metabasis Therapeutics, Inc. Amended and Restated Severance Agreement
12/34/56
EX-10.1
from 10-Q 11 pages Metabasis Therapeutics, Inc. Amended and Restated Severance Agreement
12/34/56
EX-10.20
from 10-K 10 pages Metabasis Therapeutics, Inc. Severance Agreement
12/34/56
EX-10.19
from 10-K 1 page Addendum to Employment Offer Letter
12/34/56
EX-10.18
from 10-K 2 pages This Letter Is to Confirm Our Offer to You to Join Metabasis Therapeutics, Inc. as an Executive Director Reporting to Howard Foyt, M.D., PH.D. in the Clinical Development Department. the Details of This Offer Are Contingent Upon the Approval of the Board of Directors. the Following Will Be the Basic Terms of Your Employment With the Company: Title: Executive Director, Clinical Development Start Date: September 29, 2006 or Before October 03, 2006 Salary: $220,000 Per Year Payable Bi-Weekly, Less Standard Deductions and Withholdings Barry Gumbiner, M.D. September 06, 2006 Page 2 of 2 Assuming 100% Attainment of Individual and Company Goals. You Must Be Employed on the Date the Bonus Is Awarded to Earn Any Portion of the Bonus
12/34/56
EX-10.15
from 10-K 11 pages Metabasis Therapeutics, Inc. Amended and Restated Severance Agreement
12/34/56
EX-10.12
from 10-K 11 pages Metabasis Therapeutics, Inc. Amended and Restated Severance Agreement
12/34/56
EX-10.8
from 10-K 1 page November 4, 2005 Howard Foyt, M.D., PH.D. 1205 Sierra Linda Drive Escondido, Ca 92025 Dear Howard
12/34/56
EX-10.7
from 10-K 2 pages Thursday, September 15, 2005 Howard Foyt, M.D., PH.D. 1205 Sierra Linda Drive Escondido, Ca 92025 Dear Howard: This Is to Confirm Our Offer to You to Join Metabasis Therapeutics, Inc. as a Vice President in the Clinical Development Department. the Following Will Be the Basic Terms of Your Employment With the Company: Title: Vice President, Clinical Development Start Date: October 3, 2005 Salary: $230,000 Per Year Payable Bi-Weekly, Less Standard Deductions and Withholdings
12/34/56